The authors would like to thank Qiuli Wang, Language Resource Center, Colby College, for technical assistance with video processing and Eric Thomas, department of music, Colby College, for providing the background music. This project was supported by grants from the National Center for Research Resources, INBRE (P20RR016463-12), the National Institute for General Medical Sciences (P20 GM103423-12), Nationals Institutes of Health and Science Division Grant, Colby College (STA). JL and LWM were supported by grants from Summer Scholar Fund, Colby College.

1. Drosophila Startle-induced Locomotion Assay
<ol>
	<li>Drug Treatment
	<ol>
		<li>Sedate to immobilize desired number (approximately 8-12) of 1-3 day-old male flies using CO2 and transport them to vials containing the drug-supplemented food. Note: Another anesthetic e.g., ether or ice can be used to sedate flies to enable counting and handling.</li>
		<li>Allow flies to recover from sedation for 20 min (or until recovery) with the vial in a horizontal position (to prevent flies getting stuck on food) and then place the vial upright in a 12 hr dark, 12 hr light incubator at 25 &#176;C for the remainder of the experiment.</li>
	</ol>
	</li>
	<li>Experimental Set Up
	<ol>
		<li>Divide this double vial setup into three equal sections of 6.33 cm by marking circles around the vials with a permanent marker.</li>
		<li>After 3 days of drug exposure, transfer flies without anesthetizing into the bottom vial and quickly place the top vial over the opening. Tape the two vials together with clear tape.</li>
		<li>Allow flies to acclimate to the new environment for 15 min.</li>
		<li>Place vials on a white background and set up a digital camera at an appropriate distance from the double vial apparatus with a timer in view. Ensure the entire apparatus is visible in a single picture frame and that all flies are in focus. To maintain consistent frames between trials, mark the location of camera and vial.</li>
	</ol>
	</li>
	<li>Mobility Assay
	<ol>
		<li>Clearly display the trial number, drug treatment, and timer in camera view.</li>
		<li>Firmly tap the double vial apparatus against the countertop 3 times and ensure that all flies fall to the bottom of the vial. Simultaneously start the timer.</li>
		<li>Every 5 sec for 1 min, take a picture of the apparatus. Note: Alternatively, a video could be captured and paused at appropriate intervals for measurements.</li>
		<li>Allow flies to recover undisturbed for 1 min.</li>
		<li>Repeat 2 more times with 1 min recovery time between each trial. Note: Each apparatus should take 5 min to complete data collection. Maintain similar force of tapping between trials. Multiple (at least 3) apparatus can be easily handled simultaneously.</li>
	</ol>
	</li>
	<li>Data Analysis
	<ol>
		<li>Review pictures and record the number of flies in each section over time. Calculate the percentage of flies in each section over time. Notes: Repeat this entire procedure with the same flies at 2 or 3 time points of interest, for example, day 3, 5, and 7. If too many flies die throughout the experiment it is possible to scale up the original trial number to compensate for the mortality. Use appropriate statistical analysis to compare the data.</li>
	</ol>
	</li>
</ol>
2. Drosophila Spontaneous Locomotion Assay
<ol>
	<li>Food Preparation
	<ol>
		<li>Reconstitute 3 g of instant Drosophila medium with 15 ml of de-ionized water and desired rotenone (or another drug of interest) dosage.</li>
		<li>Once the food mixture has become firm (about 5 min), carefully load the food to be approximately 1 cm high into manufacturer supplied transparent tubes (5 mm X 65 mm). Add the drug infused food to the tubes by carefully placing the tubes vertically in the food and twisting them until they can be removed with the food inside the tube. Note: It is helpful to place a finger on the opening of the tube to create a vacuum. Food should not contain any air bubbles or have an uneven surface as the flies can become stuck.</li>
	</ol>
	</li>
	<li>Experimental Setup
	<ol>
		<li>Place a plastic cap on the end of tube nearest the food. Push the plastic cap on the tube as little as possible, as it can create an air bubble in the vial if pushed to forcefully.</li>
		<li>Sedate 1 day-old male flies using CO2 and carefully insert 1 male fly into each tube with a paintbrush. Repeat depending on the number of desired trials.</li>
		<li>Plug the end of the tube farthest from the food with a small cotton ball, which can be hand rolled from larger store bought cotton balls.</li>
		<li>Allow flies to recover with the tubes in a horizontal position for 15 min and ensure that all flies are alive and active. Insert the tubes into DAM and make sure that all the tubes are in the same position relative to DAM. Note: It is possible to place them with the area of monitoring at the middle of the vial, or to push all the vials to the side, so that the end of the tube is being monitored. Note: See discussion for variations on this method.</li>
	</ol>
	</li>
	<li>Data Collection
	<ol>
		<li>Place the DAM in a 12 hr dark, 12 hr light incubator set to 25 &#176;C. Connect the DAM to the data collection system. Open the DAM software and under preferences select bin length to 10 min. Start data collection and allow the program to collect data for 7 days. Note: Bin length can be adjusted if required.</li>
		<li>Data Analysis 
		Note: Process the data to obtain counts per min as a measure for long-term spontaneous locomotion.
		<ol>
			<li>Open DAM file scan program and access monitor data by clicking select input data.</li>
			<li>Select appropriate monitor range and select bin length to 10 min intervals.</li>
			<li>In output file type choose channel files. Leave all other options as default.</li>
			<li>Click scan data and save to a designated folder.</li>
			<li>Import data in a circadian data analysis software to obtain counts per min. Note: For data analysis Clocklab software is commonly used. Other options are also available.</li>
		</ol>
		</li>
	</ol>
	</li>
</ol>

<ol>
	<li>Olanow, C. W., Tatton, W. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Etiology+and+pathogenesis+of+Parkinson's+disease.">Etiology and pathogenesis of Parkinson's disease.</a> Annual review of neuroscience. 22, 123-144 (1999).</li><li>Coulom, H., Birman, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Chronic+exposure+to+rotenone+models+sporadic+Parkinson's+disease+in+Drosophila+melanogaster.">Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster.</a> The Journal of neuroscience : the official journal of the Society for Neuroscience. 24, 10993-10998 (2004).</li><li>Hosamani, R., Ramesh, S. R., Muralidhara, <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Attenuation+of+rotenone-induced+mitochondrial+oxidative+damage+and+neurotoxicty+in+Drosophila+melanogaster+supplemented+with+creatine.">Attenuation of rotenone-induced mitochondrial oxidative damage and neurotoxicty in Drosophila melanogaster supplemented with creatine.</a> Neurochemical research. 35, 1402-1412 (2010).</li><li>Islam, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+neuroprotective+role+of+the+human+uncoupling+protein+2+(hUCP2)+in+a+Drosophila+Parkinson's+disease+model.">A neuroprotective role of the human uncoupling protein 2 (hUCP2) in a Drosophila Parkinson's disease model.</a> Neurobiology of disease. 46, 137-146 (2012).</li><li>Lawal, H. O., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+Drosophila+vesicular+monoamine+transporter+reduces+pesticide-induced+loss+of+dopaminergic+neurons.">The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons.</a> Neurobiology of. 40, 102-112 (2010).</li><li>St Laurent, ., O'Brien, R., M, L., Ahmad, S. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Sodium+butyrate+improves+locomotor+impairment+and+early+mortality+in+a+rotenone-induced+Drosophila+model+of+Parkinson's+disease.">Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease.</a> Neuroscience. 246, 382-390 (2013).</li><li>Sherer, T. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanism+of+toxicity+in+rotenone+models+of+Parkinson's+disease.">Mechanism of toxicity in rotenone models of Parkinson's disease.</a> The Journal of neuroscience : the official journal of the Society for Neuroscience. 23, 10756-10764 (2003).</li><li>Munoz-Soriano, V., Paricio, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Drosophila+models+of+Parkinson's+disease:+discovering+relevant+pathways+and+novel+therapeutic+strategies.">Drosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies.</a> Parkinson's disease. , 520640 (2011).</li><li>Steffan, J. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Histone+deacetylase+inhibitors+arrest+polyglutamine-dependent+neurodegeneration+in+Drosophila.">Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.</a> Nature. 413, 739-743 (2001).</li><li>Auluck, P. K., Bonini, N. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Pharmacological+prevention+of+Parkinson+disease+in+Drosophila.">Pharmacological prevention of Parkinson disease in Drosophila.</a> Nature medicine. 8, 1185-1186 (2002).</li><li>Whitworth, A. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Increased+glutathione+S-transferase+activity+rescues+dopaminergic+neuron+loss+in+a+Drosophila+model+of+Parkinson's+disease.">Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease.</a> Proceedings of the National Academy of Sciences of the United States of America. 102, 8024-809 (2005).</li><li>Ahmad, S. T., Steinmetz, S. B., Bussey, H. M., Possidente, B., Seggio, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Larval+ethanol+exposure+alters+free-running+circadian+rhythm+and+per+Locus+transcription+in+adult+D.+melanogaster+period+mutants.">Larval ethanol exposure alters free-running circadian rhythm and per Locus transcription in adult D. melanogaster period mutants.</a> Behavioural brain research. 241, 50-55 (2013).</li><li>Seggio, J. A., Possidente, B., Ahmad, S. T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Larval+ethanol+exposure+alters+adult+circadian+free-running+locomotor+activity+rhythm+in+Drosophila+melanogaster.">Larval ethanol exposure alters adult circadian free-running locomotor activity rhythm in Drosophila melanogaster.</a> Chronobiology international. 29, 75-81 (2012).</li><li>Chaudhuri, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Interaction+of+genetic+and+environmental+factors+in+a+Drosophila+parkinsonism+model.">Interaction of genetic and environmental factors in a Drosophila parkinsonism model.</a> The Journal of neuroscience : the official journal of the Society for Neuroscience. 27, 2457-2467 (2007).</li><li>Feany, M. B., Bender, W. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+Drosophila+model+of+Parkinson's+disease.">A Drosophila model of Parkinson's disease.</a> Nature. 404, 394-398 (2000).</li><li>Ali, Y. O., Escala, W., Ruan, K., Zhai, R. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Assaying+locomotor,+learning,+and+memory+deficits+in+Drosophila+models+of+neurodegeneration.">Assaying locomotor, learning, and memory deficits in Drosophila models of neurodegeneration.</a> Journal of Visualized Experiments : JoVE. , (2011).</li><li>Gargano, J. W., Martin, I., Bhandari, P., Grotewiel, M. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapid+iterative+negative+geotaxis+(RING):+a+new+method+for+assessing+age-related+locomotor+decline+in+Drosophila.">Rapid iterative negative geotaxis (RING): a new method for assessing age-related locomotor decline in Drosophila.</a> Experimental gerontology. 40, 386-395 (2005).</li><li>Nichols, C. D., Becnel, J., Pandey, U. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Methods+to+assay+Drosophila+behavior.">Methods to assay Drosophila behavior.</a> Journal of visualized experiments : JoVE. , (2012).</li><li>Slawson, J. B., Kim, E. Z., Griffith, L. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=High-resolution+video+tracking+of+locomotion+in+adult+Drosophila+melanogaster.">High-resolution video tracking of locomotion in adult Drosophila melanogaster.</a> Journal of Visualized Experiments : JoVE. , (2009).</li></ol>

The authors have nothing to disclose.

In this study, we describe two procedures for measuring both long-term spontaneous locomotion and short-term startle-induced locomotion in a rotenone-induced Drosophila model of Parkinson&#8217;s disease. One can also measure these locomotion characteristics in flies exposed to other pharmacological agents known to model Parkinson&#8217;s disease e.g., paraquat14, genetic models of Parkinson&#8217;s disease e.g., alpha-synuclein mutants15, and other fly models of diseases ...

Locomotion deficiencies are a major symptom of Parkinson&#8217;s disease and are largely caused by deterioration of dopaminergic neurons of the substantia nigra1. Rotenone is a ketonic insecticide that has been studied extensively to model Parkinson&#8217;s motor deficits in Drosophila2-6. Rotenone causes oxidative damage by blocking the oxidative phosphorylation pathway, which ultimately causes cell death7. Dopaminergic neurons are more prone to rotenone toxicity, making the effects of the chemical primarily motor based2,7. By inducing Parkinson&#8217;s disease symptoms in flies, we can better understand the disease and remedy its symptoms6,8-11. Drosophila provides a good model for studying this effect because they are genetically tractable, easy to maintain, and have a rapid life cycle.
Several studies have shown that rotenone causes short-term startle-induced locomotion defects in Drosophila&#8212;when flies are maintained on rotenone-supplemented food, they show a slower negative geotactic response after startle2-6. Their failure to climb upwards in a vial apparatus as quickly as control trials is indicative of startle-induced locomotion defects.
The effect of rotenone on long-term, spontaneous movement is not well described. Drosophila activity monitors (DAMs) have been successfully used to monitor movement in Drosophila circadian rhythm studies12,13. Flies are placed in individual tubes, which are loaded into the DAM. This apparatus is equipped with an infrared sensor, which counts the number of times a fly breaks the infrared beam. These counts can be used as a measure of undisturbed locomotion and activity12,13. By placing flies in a DAM, the effect of rotenone on their long-term locomotion can be characterized. This study describes methods to measure short-term startle-induced locomotion and long-term spontaneous locomotion in order to better understand the effects of rotenone mediated motor deficiencies. Characterization of locomotion deficiencies mimicking Parkinson&#8217;s disease are important because they allow for the study of other compounds which may reverse these locomotion defects.

<table border="0" cellpadding="0" cellspacing="0" width="628">
	<tbody>
		<tr height="40">
			<td height="40" style="height:40px;width:216px;">Standard narrow vials</td>
			<td style="width:127px;">Genesee Scientific</td>
			<td style="width:119px;">32-120</td>
			<td style="width:167px;"></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:216px;">Rotenone</td>
			<td style="width:127px;">Sigma</td>
			<td style="width:119px;">R8875</td>
			<td>Store in freezer, make fresh for each experiment</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:216px;">Dimethyl Sulfoxide (DMSO)</td>
			<td style="width:127px;">Sigma</td>
			<td style="width:119px;">D8418</td>
			<td>Solvent for rotenone</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:216px;">Instant Drosophila medium</td>
			<td style="width:127px;">Carolina Biological&#160;</td>
			<td style="width:119px;">Formula 4-24</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:216px;">Drosophila activity monitor (DAM)</td>
			<td style="width:127px;">Trikinetics</td>
			<td style="width:119px;">DAM2</td>
			<td>trikinetics.com</td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:216px;">DAM tubes</td>
			<td style="width:127px;">Trikinetics</td>
			<td style="width:119px;">Tubes 5X65 mm</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;width:216px;"></td>
			<td style="width:127px;"></td>
			<td style="width:119px;"></td>
			<td></td>
		</tr>
		<tr height="41">
			<td height="41" style="height:41px;width:216px;">Recipe for Rotenone +food (125 mM dose)</td>
			<td style="width:127px;"></td>
			<td style="width:119px;"></td>
			<td>Make 62.5 mM rotenone stock solution in DMSO by dissolving 25 mg rotenone in 1 ml DMSO&#160;</td>
		</tr>
		<tr height="21">
			<td height="21" style="height:21px;width:216px;"></td>
			<td style="width:127px;"></td>
			<td style="width:119px;"></td>
			<td>For 125 mM dose, add 10 mM rotenone stock in DMSO to 5 ml water.</td>
		</tr>
	</tbody>
</table>

methods to characterize spontaneous and startle-induced locomotion in a rotenone-induced parkinson's disease model of drosophila

Parkinson&#8217;s disease is a neurodegenerative disorder that results from the degeneration of dopaminergic neurons in the central nervous system, primarily in the substantia nigra. The disease causes motor deficiencies, which present as rigidity, tremors and dementia in humans. Rotenone is an insecticide that causes oxidative damage by inhibiting the function of the electron transport chain in mitochondria. It is also used to model Parkinson&#8217;s disease in the Drosophila. Flies have an inherent negative geotactic response, which compels them to climb upwards upon being startled. It has been established that rotenone causes early mortality and locomotion defects that disrupt the flies&#8217; ability to climb after they have been tapped downwards. However, the effect of rotenone on spontaneous movement is not well documented. This study outlines two sensitive, reproducible, and high throughput assays to characterize rotenone-induced deficiencies in short-term startle-induced locomotion and long-term spontaneous locomotion in Drosophila. These assays can be conveniently adapted to characterize other Drosophila models of locomotion defects and efficacy of therapeutic agents.

Drosophila Startle-induced Locomotion Assay
Wildtype, canton-S, flies showed a robust negative geotactic response with only approximately 88% and 5% of flies in the top and bottom sections respectively, of the double-vial apparatus after 30 sec (Figure 1). Flies exposed to 125 &#956;M and 250 &#956;M rotenone for 3 days showed a slight decrease in the number of flies in the top section and slight increase in the number of fli...

Watch this Scientific Journal Video about Methods to Characterize Spontaneous and Startle-induced Locomotion in a Rotenone-induced Parkinson's Disease Model of Drosophila at JoVE.com

Methods to Characterize Spontaneous and Startle-induced Locomotion in a Rotenone-induced Parkinson&#039;s Disease Model of Drosophila

Parkinson&#8217;s disease is a neurodegenerative disorder that results from the degeneration of dopaminergic neurons in the central nervous system, causing locomotion defects. Rotenone models Parkinson&#8217;s disease in Drosophila. This paper outlines two assays that characterize both spontaneous and startle-induced locomotion deficiencies caused by rotenone.

Methods to Characterize Spontaneous and Startle-induced Locomotion in a Rotenone-induced Parkinson's Disease Model of Drosophila

Parkinson&#8217;s disease is a neurodegenerative disorder that results from the degeneration of dopaminergic neurons in the central nervous system, ...

methods-to-characterize-spontaneous-startle-induced-locomotion

Research

JoVE Journal

Neuroscience

10.0K Views.  Colby College. Parkinson’s disease is a neurodegenerative disorder that results from the degeneration of dopaminergic neurons in the central nervous system, causing locomotion defects. Rotenone models Parkinson’s disease in Drosophila. This paper outlines two assays that characterize both spontaneous and startle-induced locomotion deficiencies caused by rotenone.